FTSE 250 (MCX)

19,972.11
   
  • Change Today:
      45.52
  • 52 Week High: 20,084.79
  • 52 Week Low: 16,783.09

PureTech founder steps down as CEO to lead SeaPort spin-off

By Benjamin Chiou

Date: Tuesday 09 Apr 2024

LONDON (ShareCast) - (Sharecast News) - Clinical-stage biotherapeutics group PureTech has announced that its founding chief executive is to step down to lead SeaPort Therapeutics, a PureTech company she founded that has just raised $100m in Series A financing.
Seaport will be led by Daphne Zohar, who has run PureTech since its foundation in 2005, along Steven Paul, the former CEO of Karuna Therapeutics - the PureTech spin-off that was acquired by Briistol Myers Squibb for $14bn earlier this year.

Seaport was established by PureTech to advance certain neuropsychiatric programs and will be 61.5% owned by the company following the Series A.

PureTech said it has internally advanced Seaport's neuropsychiatric medicines programs "to a key inflection point such that the pipeline can now drive value for PureTech through an equity stake and license consideration". As such, PureTech can now share the costs of later-stage development with outside investors and direct additional resources elsewhere in the business.

This same approach, part of PureTech's 'hub-and-spoke strategy', has resulted in $1.1bn in gross proceeds so far from its stake in Karuna. PureTech still receives royalties from Karuna as well as certain milestone payments.

As part of the transition, Zohar will formally step down from the board but stay on as a senior advisor, while long-term PureTech senior executive and biotech veteran Bharratt Chowrira will succeed her as CEO, effective Tuesday.

Meanwhile, Eric Elenko, a PureTech co-founder and current chief innovation officer, has been promoted to the role of president.

"I am excited to step into the CEO role and to lead PureTech through this next phase of its evolution," Chowrira said.

"We have demonstrated the evergreen success of our hub-and-spoke R&D model of venture creation, where we are able to recycle proceeds from our founded entities into both the funding of our current and future programs to change patients' lives and capital returns for shareholders."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 19,972.11
Change Today 45.52
% Change 0.23 %
01-May-24 Close 19,926.59

Top Risers

Price Change
TIFS 141.40p +3.7%
RDW 653.50p +2.6%
VTY 1,230.00p +2.4%
TRST 191.80p +2.3%
PZC 105.20p +2.3%
CBG 468.40p +2.3%
INVP 535.50p +2.2%
MONY 222.80p +2.0%
TRN 298.60p +2.0%
FUTR 680.00p +1.9%

Top Fallers

Price Change
HSX 1,174.00p -3.5%
CMCX 250.00p -3.1%
FSFL 87.50p -2.7%
INCH 775.50p -2.4%
GCP 74.60p -2.2%
EDV 1,660.00p -2.1%
DSCV 702.00p -2.1%
COA 80.30p -1.7%
GFTU 923.70p -1.6%
GEN 431.50p -1.5%

Top of Page